Basket cover image
16 handpicked stocks

Oracle's AI Cloud Catalyst

Oracle's recent surge proves AI is revolutionizing enterprise cloud spending. These carefully selected companies represent the entire AI infrastructure supply chain — from chips to networking to security — all positioned to ride the same powerful wave.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+6

Author avatar

Han Tan | Market Analyst

Updated 3 days ago | Published at जुलाई 1

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

NVDA

NVIDIA Corporation

NVDA

Current price

$175.64

Its GPUs are essential for the AI data centers that are driving Oracle's cloud growth and the broader industry.

SMCI

Super Micro Computer, Inc.

SMCI

Current price

$43.24

As a leading provider of high-performance servers, the company's hardware is critical for building out AI cloud infrastructure like Oracle's.

ANET

Arista Networks, Inc.

ANET

Current price

$132.78

Supplies high-speed networking switches necessary for connecting servers in large-scale data centers that power AI and cloud services.

About This Group of Stocks

1

Our Expert Thinking

Oracle's 41% jump in future revenue signals a massive AI-driven spending wave across enterprise cloud infrastructure. This isn't just about one company — it's about the entire ecosystem of businesses building and securing the foundation for the AI revolution.

2

What You Need to Know

This collection spans the complete AI infrastructure supply chain: semiconductor makers, server manufacturers, network providers, data center operators, and security specialists. These companies provide the essential hardware, software, and services powering AI cloud growth.

3

Why These Stocks

Each company occupies a strategic position in the AI and cloud value chain. They're carefully selected for their exposure to the same enterprise spending surge that's propelling Oracle forward, offering a diversified approach to capitalizing on this powerful secular growth trend.

12 Month Growth Potential

Use the growth calculator to see how much investing in these assets could return over one year.

If you invested across these assets:

in 12 months it could be worth:

$1,000.00

+11.76%

Group Performance Snapshot

11.76%

Average 12 Month Profit

On average, analysts expect assets in this group to grow 11.76% over the next year.

12 of 16

Stocks Rated Buy by Analysts

12 of 16 assets in this group are rated Buy by professional analysts.

0.7%

Group Growth

This group averaged a 0.7% return last month.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

🚀

The Next Big AI Wave

Oracle's surge shows enterprises are just beginning to ramp up AI spending. This creates a multi-year tailwind for every company building the infrastructure that makes AI possible.

🔄

Beyond the Cloud Giants

While everyone watches Amazon, Microsoft, and Google, these specialized players are quietly providing the essential tech that powers the entire AI revolution—often with greater growth potential.

💼

Wall Street Is Taking Notice

Professional analysts are rapidly upgrading companies in this space as the enterprise AI spending boom accelerates, creating momentum that smart investors won't want to miss.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

The New Cost of Compliance: Investing in HR Tech

The New Cost of Compliance: Investing in HR Tech

Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.

View stocks
GLP-1s Target Liver Disease

GLP-1s Target Liver Disease

The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.

View stocks
Pharma's Digital Prescription

Pharma's Digital Prescription

Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.

View stocks
View All

Frequently Asked Questions

Everything you need to know about the product and billing.